Market Analysis of Antidiabetic Drugs in India

Diabetes mellitus is a class of diseases that affect how the body uses glucose, or blood sugar. Glucose is a vital energy source for the cells that make up muscles and tissues. It serves as the brain's main source of energy as well. The India Diabetes Care Drugs Market is estimated to be worth USD 1.7 billion in 2024 and is expected to reach USD 2.01 billion by 2029, growing at a CAGR of 3.5%. The incidence of diabetes in India is 101 million, with risk factors including race, age, obesity, physical inactivity, poor diet, behavioral behaviors, genetics, and family history. Controlling blood sugar, blood pressure, and lipid levels can help prevent diabetic complications. However, diabetes prevention and management in India face challenges such as a lack of a multisectoral approach, surveillance data, awareness of diabetes, risk factors, and access to affordable medicines. The increase in diabetes medication use in India can be attributed to growing awareness about diabetes and its complications, advancements in diabetes drug treatments, and the availability of a wide range of medications. This has led to better glycemic control and improved outcomes for many diabetic patients. Due to the increasing prevalence of diabetes in India, there is now increased focus on early detection and prevention, which has encouraged more individuals to seek medical advice and begin treatment sooner.